CJC-1295 NO DAC + Ipamorelin
CJC-1295 NO DAC + Ipamorelin
Couldn't load pickup availability
CJC-1295 NO DAC + Ipamorelin
Get it as soon as -
30 Day Trial
30 Day Trial
We're confident you'll be happy with your order! In case things don't go as planned, you have 30 days to request a refund based on our return and refund policy.
Shipping & Processing
Shipping & Processing
Our shipping services are designed to be fast and reliable, ensuring your order is delivered promptly. Please allow 5-10 business days for delivery.
Track My Order
Track My Order
Once your order is shipped, we will provide you with a tracking number to monitor the progress of your shipment on our website or the shipping carrier's website. You can track your order here Track My Order
Each vial contains 10 mg of EACH CJC-1295 no DAC + Ipamorelin in lyophilized form.
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog designed to increase growth hormone (GH) and IGF-1 levels for muscle growth, fat loss, anti-aging, and recovery. It stimulates the pituitary gland to produce GH, mimicking the body’s natural process.
CJC-1295 without DAC: Has a short half-life (~30 minutes), requiring frequent dosing for GH pulses.
Ipamorelin is a growth hormone secretagogue (GHS) and selective ghrelin receptor agonist that stimulates the release of growth hormone (GH). It is often used for anti-aging, muscle growth, fat loss, and recovery.
01The PureChain Standard
Purity And Documentation
Your results are only as good as the compound you start with.
Every vial is labelled with its compound, vial size and molecular weight, and ships for laboratory research use only. Third-party testing details will be published here.
Supplied for in-vitro laboratory research only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
- Size
- 20mg
- Form
- Lyophilized powder
- Storage
- −20 °C, protected from light
- Components
- CJC-1295 No DAC · Ipamorelin
About This Compound
About CJC-1295 No DAC + Ipamorelin
This vial holds two peptides that act on the same output through two different receptors. CJC-1295 without DAC is a GHRH(1-29) analog that stimulates the pituitary’s growth hormone-releasing hormone receptor. Ipamorelin is a selective agonist at the growth hormone secretagogue receptor – the ghrelin receptor – which is an entirely separate pathway to the same cells. Pairing them is the standard way to study whether two independent inputs to growth hormone release are additive. As a two-component blend it carries no single molecular weight, formula or CAS.
Two-Component Blend · GHRH Analog + Ghrelin Receptor Agonist
Form
Vial Size
02Molecular Structure · Component 1 Of 2
The Ipamorelin molecule
An illustrative atomic representation generated from the compound record, alongside its verified molecular data. The structure figure is schematic – not a measured conformation.
- C
- H
- N
- O
- S/P
Molecular data from the public PubChem record (CID 9831659). View on PubChem
By The Numbers
CJC-1295 No DAC + Ipamorelin Research, By The Numbers
The figures that define CJC-1295 No DAC + Ipamorelin and how it is being studied. For laboratory research use only.
Components
CJC-1295 No DAC and Ipamorelin in one 20mg vial
First Pathway
The pituitary growth hormone-releasing hormone receptor
Second Pathway
The growth hormone secretagogue (ghrelin) receptor
Research Areas
- Dual-Pathway GH Studies
- Receptor Selectivity Research
- Pulsatile Release Models
- Secretagogue Pharmacology
How It Works
How CJC-1295 No DAC + Ipamorelin Works
The pathways CJC-1295 No DAC + Ipamorelin acts on, and what each one does. Described from preclinical and receptor-pharmacology literature.
The Releasing-Hormone Pathway
CJC-1295 without DAC binds the GHRH receptor on pituitary somatotrophs. It is the GHRH(1-29) fragment with four stabilising substitutions and no albumin-binding complex, so it acts over a short window and preserves pulsatile release.
- Agonist at the pituitary GHRH receptor
- Four stabilising amino acid substitutions
- Short-acting, so the pulse pattern is retained
A Separate Route To The Same Cell
Ipamorelin is a selective agonist at GHS-R1a, the ghrelin receptor. Its research value is its selectivity: unlike earlier secretagogues it shows little activity on cortisol or prolactin, so experiments are not confounded by a broader endocrine response.
- Selective agonist at the GHS-R1a ghrelin receptor
- Minimal reported cortisol or prolactin activity
- A distinct receptor from GHRH-R on the same cells
Testing Two Independent Inputs
Because the two receptors are independent, the pairing is a clean test of additivity: whether stimulating both pathways at once produces more than either alone. That question is the reason this combination appears throughout the secretagogue literature.
- Two separate receptors, one measured output
- A direct test of pathway additivity
- The standard pairing in GH secretagogue research
Uses And Applications
What CJC-1295 No DAC + Ipamorelin Is Researched For
The main areas CJC-1295 No DAC + Ipamorelin is studied in, and the qualitative magnitudes reported alongside them.
Dual-Pathway GH Studies
The defining use: measuring the growth hormone response to GHRH-R and GHS-R1a stimulation together versus separately.
Receptor Selectivity Research
Ipamorelin’s selectivity against cortisol and prolactin makes the pair useful for isolating the growth hormone axis from wider endocrine responses.
Pulsatile Release Models
Because neither component has an albumin anchor, models using this blend retain the natural pulse structure of secretion.
Secretagogue Pharmacology
Studied alongside other GH secretagogues to compare receptor routes and selectivity profiles.
Compound Information
Full Specification
| Chemical Name | CJC-1295 without DAC and Ipamorelin (two-component blend) |
|---|---|
| Form | Lyophilized powder |
| Solubility | Both components water-soluble |
| Storage | Store lyophilized at −20 °C, protected from light and moisture |
| Vial Size | 20mg |
FAQ
Common Questions About CJC-1295 No DAC + Ipamorelin
What Is In This Vial?
Two peptides: CJC-1295 without DAC, a GHRH(1-29) analog, and Ipamorelin, a selective ghrelin receptor agonist. Total 20mg.
Why Combine A GHRH Analog With A Ghrelin Agonist?
Because they reach the same output through separate receptors. Pairing them is how researchers test whether two independent inputs to growth hormone release are additive.
What Makes Ipamorelin Selective?
Unlike earlier growth hormone secretagogues, it shows little reported activity on cortisol or prolactin, so it does not bring a broader endocrine response into the experiment.
Why Is There No Molecular Weight Or CAS On This Page?
Because this vial contains two molecules. A single set of chemistry values would not describe it, and no value is published here that does not come from a matching PubChem record.
Is This Blend Approved For Human Use?
No. It is supplied as a research chemical for in-vitro laboratory work only.
How Should This Blend Be Stored?
Store the lyophilized powder at −20 °C, protected from light and moisture, and refrigerate once reconstituted. Aliquot rather than repeatedly freezing and thawing.
Feedback
WHAT OUR CUSTOMERS HAVE TO SAY...
"Been using PureChain Labs for 9 months now. In my opinion, it's the best source in Canada. Quality product every time and gives me the best results. Also the communication is second to none, I get a response in minutes usually. Overall extremely happy with the service and product they provide."
"A+ service and communication. Delivery is always quick and packaged safe and sound... I love how they are transparent and you know what your getting and for using a new source for the first time that's a huge relief."
"Took a month but hair felt thicker at roots, gave me hope after months of thinning, they definitely sell quality peptides."
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA or Health Canada; this product is not intended to diagnose, treat, cure or prevent any disease.